Raltegravir is an antiretroviral drug used in the treatment of HIV. It belongs to a class of medications known as integrase strand transfer inhibitors (INSTIs). These inhibitors block the action of the HIV integrase enzyme, which is essential for the viral replication process. Raltegravir is marketed under the brand name Isentress and was the first HIV integrase inhibitor approved by the FDA.
